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Charles Stiller and colleagues at the Childhood Cancer Research
Group (CCRG) in Oxford have published the first comprehensive
overview of records held in the National Registry of Childhood
Tumours (NRCT) since its inception. This is the longest
established national population-based childhood cancer registry
in the world. As of 2006, it includes nearly 80000 cases, based on
data collected prospectively since 1962 to the present day.
Contributions by Gerald Draper, who headed the CCRG from its
inception through to 2002, describe the evolution of the Registry
with its increasing completeness of case ascertainment and data
quality. One of the strengths of the NRCT is the ability within the
British National Health Service to ‘flag’ survivors so that the NRCT
receives notification of their death or development of any
subsequent cancer. This means that follow-up for mortality is
virtually complete within Great Britain.
The NRCT has become an exemplar for establishing childhood
cancer registries around the world. It is recognised to have
extremely complete data, partly due to notification of cases from
multiple sources, aided by the close relationship between the
CCRG and the main childhood cancer clinical trials organisation in
the UK (UK Children’s Cancer Study Group, now known as the
Children’s Cancer and Leukaemia Group).
Owing to the long established high quality of case ascertainment,
the NRCT is able to produce robust data on incidence of the main
subtypes of childhood cancers and their changes in incidence over
a 35-year period. These data confirm those seen across Europe and
in some other Western populations that the overall incidence of
childhood cancer is increasing by almost 1% per year over the last
30 years. The NRCT provides a valuable resource for further
epidemiological research into why this should be. The ability to
link records to information held on birth certification, such as
parental occupation and extremely accurate location of birth due
to the British postal code system, which can be linked to socio-
economic status and environmental exposures, provides rich
avenues for future research to investigate this phenomenon.
There is a detailed analysis of survival by cancer type and
subtype for those treated in the most recent era for which 5-year
survival are mature (i.e. 1991–2000). These are very valuable data
for researchers interested in outcome according to biological basis
of disease, due to the very detailed information collected by the
CCRG, which is often not available to other cancer registries. These
items include extra data on laterality for retinoblastoma and renal
tumours and immunophenotyping for leukaemias and lympho-
mas. For cases diagnosed between 1991 and 2000, such data were
complete for 495% and approximately 80% of cases, respectively.
Time trends in survival across successive quinquennia from
1966–1970 to 1996–2000 are also presented, showing encouraging
and significant improvements for all diagnostic groups. The
stubborn subgroups for which survival remains at less than 50% in
the most recent period are highlighted.
The section on long-term survival for those who have achieved
5-year survival from original diagnosis, according to the quin-
quennium of their original diagnosis, will be of interest both to
patients and to clinicians alike. It is reassuring to see that for the
vast majority of childhood cancers, 5-year survival equates to an
extremely good chance of much longer term survival, usually far in
excess of 90%.
Finally, this book presents complete national data on mortality
and trends in mortality by tumour type. These are essential to
monitor the effectiveness of new therapeutic or preventative
strategies. They also emphasise the important relative ranking of
childhood cancer as a cause of death in children living in a modern
Western society: over 20% of all deaths occurring in 1- to 14-year-
olds are due to cancer and this relative proportion is increasing.
This means that general child mortality is decreasing faster than
childhood cancer mortality, emphasising that there remains much
progress to be made.
The CCRG have lain before us their international wares and invite
interested researchers to collaborate with them and maximise the
opportunities for research and increasing the knowledge of child-
hood cancer aetiology and efficacy of treatment offered by their data
collection. This book is an essential reading and a valuable reference
source for all those responsible for organising, delivering and
evaluating cancer care for children around the world.
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